Join
Live feed
·
INSIDERFilingvia Quantisnow
SAB Biotherapeutics Inc. logo

Sullivan Eddie Joe bought $1,531 worth of shares (1,740 units at $0.88), increasing direct ownership by 0.03% to 5,232,304 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SABS· SAB Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SABS (SAB Biotherapeutics Inc.) and more on Quantisnow.